311690 — CJ Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩132bn
- KR₩66bn
- KR₩3bn
Annual cashflow statement for CJ Bioscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8,763 | -19,272 | -34,913 | -22,913 | -32,838 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 837 | 10,278 | 3,138 | -8,002 | 144 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,104 | -1,005 | 6,883 | 870 | 613 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7,978 | -8,437 | -20,993 | -24,899 | -27,760 |
| Capital Expenditures | -18,866 | -979 | -4,870 | -16,417 | -584 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7,640 | 7,431 | 12,035 | 33,116 | -66,974 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26,506 | 6,453 | 7,165 | 16,699 | -67,557 |
| Financing Cash Flow Items | — | — | -250 | -261 | -312 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 42,345 | 50,711 | 1,022 | 22,944 | 39,499 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7,901 | 48,805 | -12,737 | 14,772 | -55,786 |